SUD 14.3% 0.3¢ suda pharmaceuticals ltd

Originally posted by DooleYes, but we haven't received the TGA...

  1. 5,194 Posts.
    lightbulb Created with Sketch. 192
    Yes the MAA was submitted on or about 6 December 2017 - its now 16 April 2019 - So now 4 months late but compare to Artimist not that bad as TGA MAA for Artiminst was expected April last year so its over 12 months late

    PERTH, AUSTRALIA – 6 December 2017: SUDA Pharmaceuticals Ltd (ASX: SUD), a leaderin oro-mucosal drug delivery, today announced that its licensee,
    Teva PharmaceuticalIndustries Ltd., has submitted its first Marketing Authorization Application for ZolpiMistin the licensed territory.In July 2017, SUDA and Teva entered a licence and supply agreement for ZolpiMistcovering multiple countries.
    The regulatory review process is expected to take 12 months with approval of ZolpiMistanticipated in Q4 2018.
    Under the terms of the agreement with Teva, the approval ofZolpiMist triggers a milestone payment to SUDA.
watchlist Created with Sketch. Add SUD (ASX) to my watchlist
(20min delay)
Mkt cap ! $7.745M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $4.92K 1.473M

Buyers (Bids)

No. Vol. Price($)
44 27891797 0.3¢

Sellers (Offers)

Price($) Vol. No.
0.4¢ 20654004 21
View Market Depth
Last update - 15.19pm 24/04/2019 (20 minute delay) ?
SUD (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.